Interactive Transcript
0:01
So the next topic we need to cover in
0:03
evaluating Crohn's is how do we distinguish
0:04
inflammation from fibrotic processes?
0:07
Because oftentimes Crohn's is a mixture of both.
0:11
However, the gastroenterologists and surgeons
0:13
really want to know if one or the other is
0:15
predominant because the treatment is very different.
0:18
The treatment for inflammatory or inflammation
0:22
disease is vastly different from fibrotic disease.
0:26
Inflammation is treated very differently
0:28
from fibrosis, and inflammation you see is
0:31
treated with steroids and immunologics.
0:33
So the gastroenterologist is really in charge of that.
0:36
However, when it's a predominantly
0:37
fibrotic process, the steroids and
0:39
immunologics no longer are going to work.
0:41
And it's come beyond that and really it's a
0:44
diet, so restrictive diet, trying to eat things
0:47
that prevent bowel obstructions because of the
0:49
strictures that you get with fibrosis, or it's
0:51
surgery and that's when the surgeons need to get
0:53
involved, but they don't want to get involved if
0:56
it's primarily inflammatory component which can
0:58
still be treated with steroids and immunologics.
1:02
So the way we differentiate these is
1:04
looking at the features on imaging and
1:06
really, MRI is the best way to do this.
1:09
CT isn't going to get you very far compared to
1:11
MRI in terms of what you can tell about what's
1:14
actually going on in the acute versus chronic piece.
1:18
So for the inflammatory cases, they have early
1:21
enhancement, a high T2 signal because of the edema.
1:25
And then they also can have ulceration
1:27
of the mucosa and blurred margins.
1:29
And those things are all highly specific for inflammation.
1:33
That is highly specific for inflammation.
1:35
Fibrosis, on the other hand, has more of a
1:36
progressive enhancement, and this is where
1:38
those seven-minute images are really helpful
1:41
to see, is it more or less enhancing on seven
1:44
compared to the earlier enhancing sequences.
1:47
The signal component on the T2 will be
1:49
dependent on how much edema there is, so
1:52
because fibrosis and inflammation coexist, just
1:55
because it's edematous doesn't mean it's not
1:57
also fibrotic, so that's important to remember.
2:00
And then, lastly, the ulcerative and blurred
2:03
margins are predictors of inflammation
2:06
and don't necessarily say whether there's
2:08
also a fibrosis component on top of that.
2:11
So really in the end, what you end
2:12
up with is a two-by-two kind of table.
2:15
And so this is a nice paper that kind of
2:17
looked at this, and this specifically was
2:20
looking at the importance of those seven-minute
2:22
delayed images and what we can do with those.
2:24
And
2:26
if you use that in conjunction with
2:27
your T2 signal, you can really break
2:29
most cases into one of four categories.
2:32
So if it's low inflammation and there's no fibrosis,
2:38
what you get is a normal signal intensity T2,
2:42
and then you don't have more enhancement at seven minutes.
2:46
On the other side, if you get low inflammation and
2:49
marked fibrosis, you have that normal T2 signal.
2:52
But you do get the delayed enhancement because
2:54
the delayed enhancement indicates fibrosis.
2:56
When you have those with severe
2:59
inflammation, then you have edema on T2, and you
3:03
don't have more enhancement on the delayed phase.
3:06
And when you have marked fibrosis and severe
3:08
inflammation, so when both are present, you get the
3:10
delayed enhancement, and you get the appearance.
3:13
And so we're going to look at some cases showing how we
3:15
can use that in practice because it's really helpful.
3:18
And when I get questions from my gastroenterologist,
3:21
almost 100% of the time,
3:23
they want to know is it acute or chronic
3:24
and should I ramp up my immunologics or
3:28
should I refer this person to a surgeon?
3:31
So we're going to look at some cases trying
3:33
to get you able to answer that question.
© 2024 Medality. All Rights Reserved.